The A, B, Cs (along with CDCs and FDAs) of Regulatory Implications over Assisted Reproductive Technology
Marla Neufeld's article was just published in the December 2019 issue of the American Bar Association's Health Lawyer
publication. The article is titled, The A, B, Cs (along with CDCs and FDAs) of Regulatory Implications over Assisted Reproductive Technology
and Ms. Neufeld was joined by Reed Smith health law partner, Kimberly Gold, Esq. in writing the article.
Introduction to Assisted Reproductive Technology
The article provides a brief overview of assisted reproductive technology history in the United States. It then discusses the typical medical procedures involved in assisted reproductive technology and traditional surrogacy compared to gestational surrogacy. The article then provides an overview of the various laws, agencies, organizations, and regulations that govern assisted reproductive technology such state laws, constitutional principles, the American Society for Reproductive Medicine, the Center for Disease Control and Prevention and the Food and Drug Administration, to name a few.
Privacy and Cybersecurity Concerns in Emerging ART Technology
The article then provides a fascinating look into the recent expansion of assisted reproductive technology into more unique advancements in tools such as fertility and period tracking applications, female health tracking features, smart tampons, and other women's health technologies coined as "Femtech". The article discussed privacy concerns associated with these emerging technologies and how the Femtech business has adapted as it evolves to keep in line with evolving cybersecurity and privacy concerns.
ABA members can access the article here and if you are interested in the full article. please email Ms. Neufeld at email@example.com.